Top
| Basic considerations | |
| Origin of AIDS | p. 3 |
| Etiology of AIDS: Biology of Human Retroviruses | p. 13 |
| The Molecular Biology of HIV-1 | p. 39 |
| Immunopathogenesis of HIV Infection | p. 61 |
| Immune Responses to HIV Infection | p. 77 |
| Epidemiology | |
| Global Aspects of the HIV Epidemic | p. 89 |
| Epidemiology of HIV in the United States | p. 99 |
| Transmission of the Human Immunodeficiency Virus | p. 111 |
| Clinical Manifestations | |
| Clinical Spectrum of HIV Disease | p. 123 |
| Serologic Tests for Human Immunodeficiency Virus | p. 141 |
| Infectious Complications of HIV | p. 157 |
| Pneumocystis carinii and Other Protozoa | p. 157 |
| Fungal Infections in Patients with the Acquired Immunodeficiency Syndrome | p. 167 |
| Tuberculosis and Other Bacterial Infections | p. 180 |
| Herpesvirus Infection in Individuals With HIV Infection | p. 193 |
| Kaposi's Sarcoma and the Acquired Immunodeficiency Syndrome | p. 209 |
| Lymphoma and Other Miscellaneous Cancers | p. 225 |
| Central and Peripheral Nervous System Complications of HIV-1 Infection and AIDS | p. 237 |
| Gastrointestinal Manifestations of HIV Infection and AIDS | p. 259 |
| HIV Infection in Children | p. 285 |
| Noninfectious Organ-Specific Complications of HIV Infection | p. 313 |
| Dermatologic Complications | p. 313 |
| Pulmonary Complications | p. 320 |
| Renal Complications | p. 334 |
| Hematologic Complications of HIV Infection | p. 337 |
| Psychiatric and Psychosocial Aspects of HIV Infection | p. 347 |
| Treatment of the HIV Infection | |
| Strategies and Progress in the Development of Antiretroviral Agents | p. 357 |
| Antiretroviral Therapy | p. 373 |
| Azidothymidine and Other Deoxynucleotide Analogues | p. 373 |
| Interferon-[alpha] in HIV Infection | p. 395 |
| Soluble CD4, Immunomodulators, Immunotoxins, and Other Approaches to Anti-HIV Therapy | p. 406 |
| Therapeutic Approach to the HIV-Seropositive Patient | p. 417 |
| Counseling of HIV-Infected Individuals, Their Families, and Their Partners | p. 435 |
| Prevention and Public Health | |
| Prevention of the Sexual Transmission of HIV | p. 443 |
| AIDS Among Drug Injectors: The First Decade | p. 453 |
| The Safety of Blood and Blood Products | p. 463 |
| Perinatal Transmission of HIV | p. 471 |
| AIDS Vaccines | p. 479 |
| A Human Rights Framework for Evaluating AIDS Policies: Consent, Confidentiality, and Antidiscrimination | p. 489 |
| Technical Successes and Social Failures: Approaching the Second Decade of the AIDS Epidemic | p. 497 |
| HIV Infection and the Health Care Worker | |
| Occupational Risk of HIV Infection in Health Care Workers | p. 505 |
| Safety Precautions for the Health Care Worker | p. 517 |
| General Precautions to Prevent the Transmission of Blood-Borne and Aerosolized Pathogens | p. 517 |
| Special Considerations for Surgeons | p. 529 |
| Special Considerations for Dentists | p. 538 |
| Special Considerations for Emergency Personnel | p. 543 |
| Postexposure Management of Health Care Workers Occupationally Exposed to HIV | p. 550 |
| Sterilization, Disinfection, and Environmental Control | p. 556 |
| Management of Health Care Workers Infected With HIV or Other Blood-Borne Pathogens | p. 561 |
| Index | p. 573 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
